Algert Global LLC Invests $1.32 Million in Pediatrix Medical Group, Inc. (NYSE:MD)

Algert Global LLC acquired a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 113,435 shares of the company's stock, valued at approximately $1,315,000. Algert Global LLC owned 0.13% of Pediatrix Medical Group as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. nVerses Capital LLC acquired a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at $31,000. Innealta Capital LLC acquired a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at $33,000. Quest Partners LLC lifted its holdings in Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock worth $35,000 after buying an additional 622 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in Pediatrix Medical Group by 47.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company's stock worth $36,000 after buying an additional 1,524 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in Pediatrix Medical Group in the 2nd quarter worth $72,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on MD. Jefferies Financial Group boosted their price objective on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a "buy" rating in a report on Tuesday, November 5th. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a "neutral" rating in a report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a "hold" rating in a report on Monday, November 4th. Truist Financial upped their target price on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Finally, Mizuho upped their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a research note on Tuesday, November 19th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $16.10.

Insider Activity at Pediatrix Medical Group

In other Pediatrix Medical Group news, EVP Mary Ann E. Moore sold 8,108 shares of the company's stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the transaction, the executive vice president now owns 135,810 shares in the company, valued at approximately $2,172,960. This represents a 5.63 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Mark S. Ordan sold 27,600 shares of the company's stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total transaction of $423,660.00. Following the completion of the transaction, the director now owns 138,683 shares of the company's stock, valued at approximately $2,128,784.05. This trade represents a 16.60 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.00% of the company's stock.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD traded up $0.19 during trading on Friday, reaching $14.96. 420,728 shares of the company's stock traded hands, compared to its average volume of 862,608. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $16.41. The company has a 50 day moving average of $13.25 and a 200-day moving average of $10.21. The stock has a market capitalization of $1.28 billion, a P/E ratio of -4.89, a price-to-earnings-growth ratio of 2.10 and a beta of 1.55.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The business had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. During the same quarter in the prior year, the firm earned $0.29 EPS. The company's revenue for the quarter was up .9% compared to the same quarter last year. On average, equities analysts expect that Pediatrix Medical Group, Inc. will post 1.26 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.